96 related articles for article (PubMed ID: 1718037)
21. Mutation analysis in 600 French cystic fibrosis patients.
Chevalier-Porst F; Bonardot AM; Gilly R; Chazalette JP; Mathieu M; Bozon D
J Med Genet; 1994 Jul; 31(7):541-4. PubMed ID: 7525963
[TBL] [Abstract][Full Text] [Related]
22. Isolation of the braZ gene encoding the carrier for a novel branched-chain amino acid transport system in Pseudomonas aeruginosa PAO.
Hoshino T; Kose-Terai K; Uratani Y
J Bacteriol; 1991 Mar; 173(6):1855-61. PubMed ID: 1900503
[TBL] [Abstract][Full Text] [Related]
23. Cystic fibrosis transmembrane conductance regulator: the NBF1+R (nucleotide-binding fold 1 and regulatory domain) segment acting alone catalyses a Co2+/Mn2+/Mg2+-ATPase activity markedly inhibited by both Cd2+ and the transition-state analogue orthovanadate.
Annereau JP; Ko YH; Pedersen PL
Biochem J; 2003 Apr; 371(Pt 2):451-62. PubMed ID: 12523935
[TBL] [Abstract][Full Text] [Related]
24. cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator.
Rommens JM; Dho S; Bear CE; Kartner N; Kennedy D; Riordan JR; Tsui LC; Foskett JK
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7500-4. PubMed ID: 1715567
[TBL] [Abstract][Full Text] [Related]
25. Characterization of transmembrane domains 6, 7, and 8 of MalF by mutational analysis.
Ehrle R; Pick C; Ulrich R; Hofmann E; Ehrmann M
J Bacteriol; 1996 Apr; 178(8):2255-62. PubMed ID: 8636026
[TBL] [Abstract][Full Text] [Related]
26. Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Strong TV; Smit LS; Nasr S; Wood DL; Cole JL; Iannuzzi MC; Stern RC; Collins FS
Hum Mutat; 1992; 1(5):380-7. PubMed ID: 1284540
[TBL] [Abstract][Full Text] [Related]
27. Identification of six mutations (R31L, 441delA, 681delC, 1461ins4, W1089R, E1104X) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Zielenski J; Markiewicz D; Chen HS; Schappert K; Seller A; Durie P; Corey M; Tsui LC
Hum Mutat; 1995; 5(1):43-7. PubMed ID: 7537150
[TBL] [Abstract][Full Text] [Related]
28. The leucine binding proteins of Escherichia coli as models for studying the relationships between protein structure and function.
Antonucci TK; Landick R; Oxender DL
J Cell Biochem; 1985; 29(3):209-16. PubMed ID: 4077929
[TBL] [Abstract][Full Text] [Related]
29. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.
Chu CS; Trapnell BC; Curristin SM; Cutting GR; Crystal RG
J Clin Invest; 1992 Sep; 90(3):785-90. PubMed ID: 1381723
[TBL] [Abstract][Full Text] [Related]
30. Bacterial periplasmic permeases as model systems for multidrug resistance (MDR) and the cystic fibrosis transmembrane conductance regulator (CFTR).
Ames GF
Soc Gen Physiol Ser; 1993; 48():77-94. PubMed ID: 7684868
[No Abstract] [Full Text] [Related]
31. Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium.
Tsui LC
Hum Mutat; 1992; 1(3):197-203. PubMed ID: 1284534
[TBL] [Abstract][Full Text] [Related]
32. Cystic fibrosis gene expression is not correlated with rectifying Cl- channels.
Ward CL; Krouse ME; Gruenert DC; Kopito RR; Wine JJ
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5277-81. PubMed ID: 1711224
[TBL] [Abstract][Full Text] [Related]
33. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.
Hamosh A; Trapnell BC; Zeitlin PL; Montrose-Rafizadeh C; Rosenstein BJ; Crystal RG; Cutting GR
J Clin Invest; 1991 Dec; 88(6):1880-5. PubMed ID: 1721624
[TBL] [Abstract][Full Text] [Related]
34. Study of 12 mutations in Turkish cystic fibrosis patients.
Yilmaz E; Erdem H; Ozgüç M; Coşkun T; Ozçelik U; Göçmen A; Ozalp I
Hum Hered; 1995; 45(3):175-7. PubMed ID: 7542223
[TBL] [Abstract][Full Text] [Related]
35. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
Schwartz M
Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
[TBL] [Abstract][Full Text] [Related]
36. A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.
Will K; Dörk T; Stuhrmann M; Meitinger T; Bertele-Harms R; Tümmler B; Schmidtke J
J Clin Invest; 1994 Apr; 93(4):1852-9. PubMed ID: 7512993
[TBL] [Abstract][Full Text] [Related]
37. Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis.
McIntosh I; Cutting GR
FASEB J; 1992 Jul; 6(10):2775-82. PubMed ID: 1378801
[TBL] [Abstract][Full Text] [Related]
38. [The cystic fibrosis gene: mutation and the function of CFTR protein].
Goossens M
Ann Pediatr (Paris); 1991 Nov; 38(9):591-4. PubMed ID: 1721508
[TBL] [Abstract][Full Text] [Related]
39. ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance.
Doige CA; Ames GF
Annu Rev Microbiol; 1993; 47():291-319. PubMed ID: 7504904
[TBL] [Abstract][Full Text] [Related]
40. Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains.
Moran O; Galietta LJ; Zegarra-Moran O
Cell Mol Life Sci; 2005 Feb; 62(4):446-60. PubMed ID: 15719171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
